• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
143.96
432096.23
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.89
 

hindustan bio sciences ltd
Tijaria Polypipes reports standalone net loss of Rs 0.30 crore in the March 2026 quarter
May 27,2026
Net Loss of Tijaria Polypipes reported to Rs 0.30 crore in the quarter ended March 2026 as against net loss of Rs 3.14 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.29 crore in the year ended March 2026 as against net loss of Rs 5.43 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.